|
1
|
Parkinson DR, Dracopoli N, Petty BG,
Compton C, Cristofanilli M, Deisseroth A, Hayes DF, Kapke G, Kumar
P, Lee JSh, Liu MC, McCormack R, Mikulski S, Nagahara L, Pantel K,
Pearson-White S, Punnoose EA, Roadcap LT, Schade AE, Scher HI,
Sigman CC and Kelloff GJ: Considerations in the development of
circulating tumor cell technology for clinical use. J Transl Med.
10:1382012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cohen SJ, Punt CJ, Iannotti N, Saidman BH,
Sabbath KD, Gabrail NY, Picus J, Morse M, Mitchell E, Miller MC,
Doyle GV, Tissing H, Terstappen LW and Meropol NJ: Relationship of
circulating tumor cells to tumor response, progression-free
survival, and overall survival in patients with metastatic
colorectal cancer. J Clin Oncol. 26:3213–3221. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Riethdorf S, Fritsche H, Müller V, Rau T,
Schindlbeck C, Rack B, Janni W, Coith C, Beck K, Jänicke F, Jackson
S, Gornet T, Cristofanilli M and Pantel K: Detection of circulating
tumor cells in peripheral blood of patients with metastatic breast
cancer: a validation study of the CellSearch system. Clin Cancer
Res. 13:920–928. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Davis JW, Nakanishi H, Kumar VS,
Bhadkamkar VA, McCormack R, Fritsche HA, Handy B, Gornet T and
Babaian RJ: Circulating tumor cells in peripheral blood samples
from patients with increased serum prostate specific antigen:
initial results in early prostate cancer. J Urol. 179:2187–2191.
2008. View Article : Google Scholar
|
|
5
|
Pierga JY, Bidard FC, Mathiot C, Brain E,
Delaloge S, Giachetti S, de Cremoux P, Salmon R, Vincent-Salomon A
and Marty M: Circulating tumor cell detection predicts early
metastatic relapse after neoadjuvant chemotherapy in large operable
and locally advanced breast cancer in a phase II randomized trial.
Clin Cancer Res. 14:7004–7010. 2008. View Article : Google Scholar
|
|
6
|
Hou JM, Greystoke A, Lancashire L,
Cummings J, Ward T, Board R, Amir E, Hughes S, Krebs M, Hughes A,
Ranson M, Lorigan P, Dive C and Blackhall FH: Evaluation of
circulating tumor cells and serological cell death biomarkers in
small cell lung cancer patients undergoing chemotherapy. Am J
Pathol. 175:808–816. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fujiwara T, Kagawa S, Kishimoto H, Endo Y,
Hioki M, Ikeda Y, Sakai R, Urata Y, Tanaka N and Fujiwara T:
Enhanced antitumor efficacy of telomerase-selective oncolytic
adenoviral agent OBP-401 with docetaxel: preclinical evaluation of
chemoviro-therapy. Int J Cancer. 119:432–440. 2006. View Article : Google Scholar
|
|
8
|
Blackburn EH: Telomere states and cell
fates. Nature. 408:53–56. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim NW, Piatyszek MA, Prowse KR, Harley
CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL and Shay
JW: Specific association of human telomerase activity with immortal
cells and cancer. Science. 266:2011–2015. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bilsland AE, Merron A, Vassaux G and Keith
WN: Modulation of telomerase promoter tumor selectivity in the
context of oncolytic adenoviruses. Cancer Res. 67:1299–1307. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kojima T, Hashimoto Y, Watanabe Y, Kagawa
S, Uno F, Kuroda S, Tazawa H, Kyo S, Mizuguchi H, Urata Y, Tanaka N
and Fujiwara T: A simple biological imaging system for detecting
viable human circulating tumor cells. J Clin Invest. 119:3172–3181.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim SJ, Masago A, Tamaki Y, Akazawa K,
Tsukamoto F, Sato J, Ozawa T, Tsujino Y and Noguchi S: A novel
approach using telomerase-specific replication-selective adenovirus
for detection of circulating tumor cells in breast cancer patients.
Breast Cancer Res Treat. 128:765–773. 2011. View Article : Google Scholar
|
|
13
|
Ito H, Inoue H, Sando N, Kimura S, Gohda
K, Sato J, Murakami K, Ito S, Odaka N, Satodate H and Kudo SE:
Prognostic impact of detecting viable circulating tumour cells in
gastric cancer patients using a telomerase-specific viral agent: a
prospective study. BMC Cancer. 12:3462012. View Article : Google Scholar
|
|
14
|
Igawa S, Gohda K, Fukui T, Ryuge S, Otani
S, Masago A, Sato J, Murakami K, Maki S, Katono K, Takakura A,
Sasaki J, Satoh Y and Masuda N: Circulating tumor cells as a
prognostic factor in patients with small cell lung cancer. Oncol
Lett. 7:1469–1473. 2014.PubMed/NCBI
|
|
15
|
Takakura M, Kyo S, Nakamura M, Maida Y,
Mizumoto Y, Bono Y, Zhang X, Hashimoto Y, Urata Y, Fujiwara T and
Inoue M: Circulating tumour cells detected by a novel
adenovirus-mediated system may be a potent therapeutic marker in
gynaecological cancers. Br J Cancer. 107:448–454. 2012. View Article : Google Scholar
|
|
16
|
Vona G, Estepa L, Béroud C, Damotte D,
Capron F, Nalpas B, Mineur A, Franco D, Lacour B, Pol S, Bréchot C
and Paterlini-Bréchot P: Impact of cytomorphological detection of
circulating tumor cells in patients with liver cancer. Hepatology.
39:792–797. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vona G, Sabile A, Louha M, Sitruk V,
Romana S, Schütze K, Capron F, Franco D, Pazzagli M, Vekemans M,
Lacour B, Bréchot C and Paterlini-Bréchot P: Isolation by size of
epithelial tumor cells: a new method for the immunomorphological
and molecular characterization of circulating tumor cells. Am J
Pathol. 156:57–63. 2000. View Article : Google Scholar
|
|
18
|
Lin HK, Zheng S, Williams AJ, Balic M,
Groshen S, Scher HI, Fleisher M, Stadler W, Datar RH, Tai YC and
Cote RJ: Portable filter-based microdevice for detection and
characterization of circulating tumor cells. Clin Cancer Res.
16:5011–5018. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zheng S, Lin HK, Lu B, Williams A, Datar
R, Cote RJ and Tai YC: 3D microfilter device for viable circulating
tumor cell (CTC) enrichment from blood. Biomed Microdevices.
13:203–213. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kishimoto H, Kojima T, Watanabe Y, Kagawa
S and Fujiwara T, Uno F, Teraishi F, Kyo S, Mizuguchi H, Hashimoto
Y, Urata Y, Tanaka N and Fujiwara T: In vivo imaging of lymph node
metastasis with telomerase-specific replication-selective
adenovirus. Nat Med. 12:1213–1219. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Broccoli D1, Young JW and de Lange T:
Telomerase activity in normal and malignant hematopoietic cells.
Proc Natl Acad Sci USA. 92:9082–9086. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Havenga MJ, Lemckert AA, Ophorst OJ, van
Meijer M, Germeraad WT, Grimbergen J, van Den Doel MA, Vogels R,
van Deutekom J, Janson AA, de Bruijn JD, Uytdehaag F, Quax PH,
Logtenberg T, Mehtali M and Bout A: Exploiting the natural
diversity in adenovirus tropism for therapy and prevention of
disease. J Virol. 76:4612–4620. 2002. View Article : Google Scholar : PubMed/NCBI
|
